Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
369
-
Total 13F shares, excl. options
-
121M
-
Shares change
-
-1.45M
-
Total reported value, excl. options
-
$7.29B
-
Value change
-
-$85.1M
-
Put/Call ratio
-
1.51
-
Number of buys
-
150
-
Number of sells
-
-168
-
Price
-
$60.41
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2019
442 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2019.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 369 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121M shares
of 159M outstanding shares and own 76.08% of the company stock.
Largest 10 shareholders include FMR LLC (21M shares), VANGUARD GROUP INC (12M shares), BAILLIE GIFFORD & CO (8.79M shares), Bellevue Group AG (8.43M shares), BlackRock Inc. (8.4M shares), Clearbridge Investments, LLC (7.95M shares), WELLINGTON MANAGEMENT GROUP LLP (6.74M shares), STATE STREET CORP (3.85M shares), Invesco Ltd. (2.36M shares), and WADDELL & REED FINANCIAL INC (2.19M shares).
This table shows the top 369 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.